LR Health & Beauty SE | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases LR Health & Beauty SE

Home
Companies
LR Health & Beauty SE

BRIEF

published on 11/28/2025 at 18:25, 6 days 10 hours ago

LR Health & Beauty SE Concludes Written Bond Procedure

LR Health & Beauty SE Bonds Written Procedure Interest Payments Temporary Waivers
PRESS RELEASE

published on 11/28/2025 at 18:20, 6 days 11 hours ago

LR HEALTH & BEAUTY SE: WRITTEN PROCEDURE UNDER THE 2024/2028 BONDS HAS BEEN SUCCESSFULLY CONCLUDED
LR Health & Beauty SE successfully concludes a written procedure under the 2024/2028 bonds, obtaining necessary votes for temporary waivers. The company specializes in nutritional supplements, cosmetics, and social commerce

Nutritional Supplements LR Health & Beauty SE Cosmetics Written Procedure 2024/2028 Bonds
BRIEF

published on 11/28/2025 at 07:35, 6 days 21 hours ago

LR Health & Beauty SE Confirms Q3 2025 Results Amid Market Challenges

Financial Results EBITDA Market Conditions LR Health & Beauty Q3 2025
PRESS RELEASE

published on 11/28/2025 at 07:30, 6 days 21 hours ago

LR Health & Beauty SE publishes final results for the third quarter of 2025
LR Health & Beauty SE releases final results for Q3 2025, with sales at EUR 208.8 million and EBITDA at EUR 16.3 million. Focus on optimizing business processes and confirming 2025 forecast

Financial Results Sustainability Forecast LR Health & Beauty SE Q3 2025
BRIEF

published on 11/25/2025 at 18:35, 9 days 10 hours ago

LR Health & Beauty SE Gains Major Bondholder Support for Temporary Waivers

LR Health & Beauty SE 2024/2028 Bonds Bondholder Support Temporary Waivers Postponement Of Payments
PRESS RELEASE

published on 11/25/2025 at 18:30, 9 days 10 hours ago

EQS-Adhoc: LR HEALTH & BEAUTY SE RECEIVES SUPPORTING VOTING INTENTIONS BY 69.57% OF THE ADJUSTED NOMINAL AMOUNT FOR TEMPORARY WAIVERS UNDER THE 2024/2028 BONDS
LR Health & Beauty SE has received support from bondholders representing 69.57% of adjusted nominal amount for temporary waivers under the 2024/2028 bonds

Bondholders LR Health & Beauty SE 2024/2028 Bonds Temporary Waivers Voting Intentions
BRIEF

published on 11/14/2025 at 15:51, 20 days 13 hours ago

LR Health & Beauty SE Seeks Bondholder Approval on Covenant Breach

LR Health & Beauty Voting Deadline Covenant Breach Bond Procedure 2024/2028 Bonds
PRESS RELEASE

published on 11/14/2025 at 15:46, 20 days 13 hours ago

LR Health & Beauty SE initiates a Written Procedure under its outstanding 2024/2028 Bonds
LR Health & Beauty SE initiates a Written Procedure among Bondholders to address an expected covenant breach regarding net debt to EBITDA ratio of 2024/2028 Bonds

Bondholders Financial LR Health & Beauty Written Procedure Leverage Covenant
BRIEF

published on 10/24/2025 at 18:55, 1 month 11 days ago

LR Health & Beauty SE Reports Q3 2025 Business Development

EBITDA Forecast Sales Decline LR Health & Beauty Q3 2025 Results Fragrance Portfolio
PRESS RELEASE

published on 10/24/2025 at 18:50, 1 month 11 days ago

LR Health & Beauty SE reports on business development in the third quarter of 2025
LR Health & Beauty SE reports on business development in Q3 2025, with sales of EUR 66.0 million and EBITDA of EUR 2.9 million. Focus on fragrance segment, capital structure, and earnings guidance revision

Sales EBITDA Business Development Fragrance LR Health & Beauty SE

1 2 ... 4

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 46 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 51 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 21 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 16 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 21 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 50 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 30 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 55 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 6 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 10 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 21 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 36 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 37 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 20 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE